Skip to content Skip to footer

From Lab to Chip: A Miniaturized Revolution in Extracellular Vesicle Analysis

  • Biomarker discovery: EVs are treasure troves of potential biomarkers for diseases like cancer, Alzheimer’s, and heart disease. Lab-on-a-chip devices can efficiently identify and characterize these biomarkers, aiding in early diagnosis.
  • Drug Delivery: EVs can be harnessed as natural carriers for drug delivery. Lab-on-a-chip devices can help engineer EVs with specific targeting abilities, ensuring drugs reach the right cells.
  • Personalized Medicine: By analyzing patient-derived EVs, these devices can provide personalized insights for diagnosis and treatment, paving the way for a more tailored approach to healthcare.
  1. Cheng, S., Li, Y., Yan, H., Wen, Y., Zhou, X., Friedman, L., & Zeng, Y. (2021). Advances in microfluidic extracellular vesicle analysis for cancer diagnostics. Lab on a Chip21(17), 3219–3243. doi:10.1039/d1lc00443c. https://pubs.rsc.org/en/content/articlelanding/2021/lc/d1lc00443c
  2. Friedrich, R., Block, S., Alizadehheidari, M., Heider, S., Fritzsche, J., Esbjörner, E. K., … Bally, M. (2017). A nano flow cytometer for single lipid vesicle analysis. Lab on a Chip17(5), 830–841. doi:10.1039/c6lc01302c. https://pubs.rsc.org/en/content/articlelanding/2017/lc/c6lc01302c
  3. Seder, I., Moon, H., Kang, S. J., Shin, S., Rhee, W. J., & Kim, S.-J. (2022). Size-selective filtration of extracellular vesicles with a movable-layer device. Lab on a Chip22(19), 3699–3707. doi:10.1039/d2lc00441k. https://pubs.rsc.org/en/content/articlelanding/2022/lc/d2lc00441k
  4. Abreu, C. M., Costa-Silva, B., Reis, R. L., Kundu, S. C., & Caballero, D. (2022). Microfluidic platforms for extracellular vesicle isolation, analysis and therapy in cancer. Lab on a Chip22(6), 1093–1125. doi:10.1039/d2lc00006g. https://pubs.rsc.org/en/content/articlelanding/2022/lc/d2lc00006g

Leave a comment